Research programme: antibacterials - PanTherixAlternative Names: PTX 007011; PTX 008134; PTX 008218; PTX 008313; PTX 008330; PTX 031553; PTX 040334; PTX 042695; PTX 110130
Latest Information Update: 08 Feb 2007
At a glance
- Originator PanTherix
- Mechanism of Action Enzyme inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bacterial infections